Home / World Marketplace / Archive by category Global Health & Biotech (Page 70)

Archive by category Global Health & Biotech

Novotech Launches Dedicated Early Phase Unit for Biotechs Leveraging the Australian and New Zealand Clinical Environment

SAN DIEGO, June 03, 2024 (Korea Bizwire) – Novotech, the global full-service Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, today announced the launch of a dedicated early phase unit focussed on leveraging the unique advantage of Australian and New Zealand (ANZ) for [...]

BioPharmaSpec Announces Major Investments in Mass Spectrometry and Related Instrumentation

The state-of-the-art instrumentation will support and accelerate BioPharmaSpec’s clients’ efforts in successful biologics product development MALVERN, Pa. and ST. SAVIOUR, Jersey, June 03, 2024 (Korea Bizwire) — BioPharmaSpec (“BioPharmaSpec”), the leading global Contract Research Organization (CRO) for discovery and preclinical characterization of biopharmaceuticals, has made major new investments in instrumentation, including top-of-the-range Mass Spectrometers, to [...]

EAACI Congress Kicks Off in Valencia, Spain

Precision Medicine, Immunotherapy, and Artificial Intelligence (AI) as Key Topics VALENCIA, Spain, May 31, 2024 (Korea Bizwire) – The EAACI International Congress has commenced with the slogan “Revolutionizing patient care through the power of data science.” Over the next four days, experts will discuss the latest advancements in this impactful area. Allergies, which represent a [...]

Nyxoah Announces Closing of Offering and Partial Exercise of Option to Purchase Additional Shares

Mont-Saint-Guibert, Belgium – May 31, 2024, 8:00am CET / 2:00am ET – Nyxoah SA (Euronext Brussels/ Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced the closing of its previously announced underwritten public offering in the United States, [...]

Biognosys Launches Groundbreaking P2 Plasma Enrichment Technology for Unbiased, Deep Plasma Proteomics at ASMS 2024

The proprietary P2 Plasma Enrichment method leverages a novel single-well, single particle-type enrichment method to achieve market-leading performance for unbiased, deep mass spectrometry-based plasma proteomics P2 now offers excellent quantitation and higher throughput for large-cohort biomarker or drug discovery studies, and clinical, epidemiological or population proteomics research P2 Plasma Enrichment is available as a CRO [...]

Biognosys Launches Spectronaut 19 and Presents Advances with Its Research Platforms at the ASMS 2024 Annual Conference

Spectronaut® 19 offers significant improvements in identifications, candidate discovery, scalability for large-scale analysis, and support for novel workflows Novel TrueDiscovery® P2 Plasma Enrichment method offers market-leading performance and superior economics for unbiased, deep plasma proteomics New TrueTarget® high-throughput LiP-MS workflow enables large-scale drug target deconvolution screening with improved target identification DigitalProteome™ database and Proteoverse™ data exploration tool help [...]

Philips Celebrates 1.9m Liters of Helium Saved As It Marks 1,111 Helium-free MRI Operations Installs, Expanding Care to More Patients in More Locations

First to provide helium-free operations in 2018, Philips marks milestone during installation in Puerto Rico May 30, 2024, Amsterdam, the Netherlands and Bayamón, Puerto Rico – (Korea Bizwire) – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and world leader in proven helium-free [1] MRI operations, today announced the 1,111th installation of its revolutionary [...]

Fortrea Introduces Comprehensive Solution to Improve Diversity and Inclusion in Clinical Research

Leverages real-world data, patient insights and a systematic process to design, operationalize and measure the effectiveness of diversity action plans in clinical trials DURHAM, N.C., May 30, 2024 (Korea Bizwire) – Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced its comprehensive and integrated solution to improve the diversity and inclusion (D&I) of [...]

Novotech Signs Strategic MOU with Hong Kong-Shenzhen Innovation and Technology Park Limited (HSITPL)

HONG KONG, May 29, 2024 (Korea Bizwire) – Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, today announced it has signed a Memorandum of Understanding (MOU) with Hong Kong-Shenzhen Innovation and Technology Park Limited (HSITPL). The MOU aims [...]

World No Tobacco Day: Addressing the “Misperception Epidemic”

GENEVA, May 30, 2024 (Korea Bizwire) – On this World No Tobacco Day, the World Vapers Alliance (WVA) is shedding light on the rampant misperception epidemic around tobacco harm reduction. As revealed by Ipsos research for the think tank, We are Innovation, a staggering 74% of smokers worldwide mistakenly believe that vaping is as harmful or more harmful than smoking. This widespread [...]